http://www.investorcalendar.com/event/25800.

For anyone unable to listen to the live conference, a replay will be available shortly after the call by dialing 1-877-481-4010 or 919-882-2331 for international callers and entering event ID 25800. A recording of the call will also be available on the Company's website for 60 days.

Company Contact:

Intellipharmaceutics International Inc.
Andrew Patient
Chief Financial Officer
416-798-3001 ext. 106
investors@intellipharmaceutics.com

Investor Contact:

ProActive Capital
Kirin Smith
646-863-6519
ksmith@pcgadvisors.com

SOURCE: Intellipharmaceutics International Inc.

ReleaseID: 489156

"/> Intellipharmaceutics Sets Earnings Release Date for Year End 2017 Results « MarketersMedia – Press Release Distribution Services – News Release Distribution Services
How It Works? Plans & Pricing Our Distributions Newsroom Info Hub Sign Up Sign In Send Press Release Contact Sales
Contact Sales Sign Up Your Account Send Press Release
MarketersMEDIA / Newsroom / Intellipharmaceutics Sets Earnings Release Date for Year End 2017 Results

Intellipharmaceutics Sets Earnings Release Date for Year End 2017 Results

Share This Press Release

TORONTO, ON / ACCESSWIRE / February 13, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI) (TSX: IPCI) (''Intellipharmaceutics'' or the ''Company''), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- and targeted-release oral solid dosage drugs, today announced that the Company intends to release its fiscal year 2017 results after market close on Thursday, February 15, 2018. Company management plans to hold a conference call at 8 am (EST) on Friday, February 16, 2018 for interested shareholders to discuss the results. The conference call will be conducted by Dr. Isa Odidi, Chairman, Chief Executive Officer, and Co-Chief Scientist and Andrew Patient, Chief Financial Officer.

Participants may access the call from North America by dialing toll-free 1-877-407-8033. International callers should dial (201) 689-8033. A webcast of the call will also be accessible at http://www.investorcalendar.com/event/25800.

For anyone unable to listen to the live conference, a replay will be available shortly after the call by dialing 1-877-481-4010 or 919-882-2331 for international callers and entering event ID 25800. A recording of the call will also be available on the Company's website for 60 days.

Company Contact:

Intellipharmaceutics International Inc.
Andrew Patient
Chief Financial Officer
416-798-3001 ext. 106
investors@intellipharmaceutics.com

Investor Contact:

ProActive Capital
Kirin Smith
646-863-6519
ksmith@pcgadvisors.com

SOURCE: Intellipharmaceutics International Inc.

ReleaseID: 489156

TORONTO, ON / ACCESSWIRE / February 13, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI) (TSX: IPCI) (''Intellipharmaceutics'' or the ''Company''), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- and targeted-release oral solid dosage drugs, today announced that the Company intends to release its fiscal year 2017 results after market close on Thursday, February 15, 2018. Company management plans to hold a conference call at 8 am (EST) on Friday, February 16, 2018 for interested shareholders to discuss the results. The conference call will be conducted by Dr. Isa Odidi, Chairman, Chief Executive Officer, and Co-Chief Scientist and Andrew Patient, Chief Financial Officer.

Participants may access the call from North America by dialing toll-free 1-877-407-8033. International callers should dial (201) 689-8033. A webcast of the call will also be accessible at http://www.investorcalendar.com/event/25800.

For anyone unable to listen to the live conference, a replay will be available shortly after the call by dialing 1-877-481-4010 or 919-882-2331 for international callers and entering event ID 25800. A recording of the call will also be available on the Company's website for 60 days.

Company Contact:

Intellipharmaceutics International Inc.
Andrew Patient
Chief Financial Officer
416-798-3001 ext. 106
investors@intellipharmaceutics.com

Investor Contact:

ProActive Capital
Kirin Smith
646-863-6519
ksmith@pcgadvisors.com

SOURCE: Intellipharmaceutics International Inc.

ReleaseID: 489156

Source URL: https://marketersmedia.com/intellipharmaceutics-sets-earnings-release-date-for-year-end-2017-results/300548

Source: AccessWire

Release ID: 300548

Latest Releases

Our Client

Subscribe and Recieve exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2018 MarketersMedia – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).